David Grinblatt to Neutropenia
This is a "connection" page, showing publications David Grinblatt has written about Neutropenia.
Connection Strength
0.019
-
A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone Marrow Transplant. 2001 Apr; 27(7):677-81.
Score: 0.012
-
Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck. Invest New Drugs. 1994; 12(1):45-7.
Score: 0.007